New AI-assisted experience supports portfolio visibility, helps identify operational risks, and recommends next best actions AUSTIN, Texas, Nov. 18, 2026 /PRNewswire/ -- Oracle today introduced Oracle Life Sciences AI Agents, a new agentic experience designed to help life sciences organizations apply intelligence and AI-assisted coordination to enhance clinical trial operations. By bringing together insights from Oracle Life Sciences applications and supported third-party data sources, the agents are designed to help clinical trial teams identify operational issues, recommend appropriate actions for review and approval, and coordinate responses across clinical development workflows.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
